| Part I: Fundamentals Of Cardiovascular Disease |
|
|
1 Global Burden of Cardiovascular Disease |
|
|
1 | (18) |
|
|
|
|
|
|
|
2 Ethics in Cardiovascular Medicine |
|
|
19 | (6) |
|
|
|
|
|
3 Clinical Decision Making in Cardiology |
|
|
25 | (8) |
|
|
|
|
|
4 Measuring and Improving Quality of Care: Relevance to Cardiovascular Clinical Practice |
|
|
33 | (6) |
|
|
|
|
|
5 Critical Evaluation of Clinical Trials |
|
|
39 | (8) |
|
|
| Part II: Genetics And Personalized Medicine |
|
|
6 Personalized and Precision Cardiovascular Medicine |
|
|
47 | (6) |
|
|
|
7 Principles of Cardiovascular Genetics |
|
|
53 | (11) |
|
|
|
|
|
8 Drug Therapeutics and Personalized Medicine |
|
|
64 | (9) |
|
|
|
9 Biomarkers and Use in Precision Medicine |
|
|
73 | (10) |
|
|
|
|
|
|
| Part III: Evaluation Of The Patient |
|
|
10 History and Physical Examination: An Evidence-Based Approach |
|
|
83 | (19) |
|
|
|
|
|
11 Anesthesia and Noncardiac Surgery in Patients with Heart Disease |
|
|
102 | (15) |
|
|
|
|
|
|
|
117 | (37) |
|
|
|
|
|
Guidelines: Electrocardiography |
|
|
151 | (93) |
|
|
|
|
|
13 Exercise Electrocardiographic Testing |
|
|
154 | (20) |
|
|
|
|
|
|
|
174 | (78) |
|
|
|
|
|
|
|
Appropriate Use Criteria: Echocardiography |
|
|
244 | (99) |
|
|
|
|
|
15 The Chest Radiograph in Cardiovascular Disease |
|
|
252 | (9) |
|
|
|
|
|
|
|
261 | (40) |
|
|
|
|
|
|
|
17 Cardiovascular Magnetic Resonance Imaging |
|
|
301 | (20) |
|
|
|
18 Cardiac Computed Tomography |
|
|
321 | (27) |
|
|
|
Appropriate Use Criteria: Multimodality Imagin in Stable Ischemic Heart Disease and Heart Failure |
|
|
343 | (71) |
|
|
|
|
|
|
|
19 Cardiac Catheterization |
|
|
348 | (26) |
|
|
|
20 Coronary Angiography and Intravascular Imaging |
|
|
374 | (29) |
|
|
|
|
| Part IV: Heart Failure |
|
|
21 Approach to the Patient with Heart Failure |
|
|
403 | (15) |
|
|
|
|
|
Guidelines: Initial Evaluation of the Patient with Heart Failure |
|
|
414 | (74) |
|
|
|
|
|
22 Mechanisms of Cardiac Contraction and Relaxation |
|
|
418 | (24) |
|
|
|
|
|
23 Pathophysiology of Heart Failure |
|
|
442 | (20) |
|
|
|
|
|
24 Diagnosis and Management of Acute Heart Failure |
|
|
462 | (28) |
|
|
|
|
|
Guidelines: The Hospitalized Patient |
|
|
488 | (28) |
|
|
|
|
|
25 Management of Heart Failure Patients with Reduced Ejection Fraction |
|
|
490 | (33) |
|
|
|
Guidelines: Management of Heart Failure with a Reduced Ejection Fraction |
|
|
516 | (26) |
|
|
|
26 Heart Failure with a Preserved Ejection Fraction |
|
|
523 | (20) |
|
|
|
|
|
Guidelines: Heart Failure with a Preserved Ejection Fraction |
|
|
542 | (9) |
|
Michael R. Zile, Sheldon E. Litwin |
|
|
27 Devices for Monitoring and Managing Heart Failure |
|
|
543 | (10) |
|
|
|
Guidelines: Cardiac Resynchronization and Implantable Cardioverter-Defibrillators in Heart Failure with a Reduced Ejection Fraction |
|
|
551 | (38) |
|
|
|
28 Surgical Management of Heart Failure |
|
|
553 | (15) |
|
|
|
|
|
|
|
29 Mechanical Circulatory Support |
|
|
568 | (12) |
|
Keith D. Aaronson, Francis D. Pagani |
|
|
30 Cardiovascular Regeneration and Repair |
|
|
580 | (9) |
|
Kiran Musunuru, Joseph C. Wu |
|
|
31 Management of Patients with Cardiovascular Disease Approaching End of Life |
|
|
589 | (8) |
|
|
|
|
| Part V: Arrhythmias, Sudden Death, And Syncope |
|
|
32 Approach to the Patient with Cardiac Arrhythmias |
|
|
597 | (7) |
|
|
|
|
|
33 Genetics of Cardiac Arrhythmias |
|
|
604 | (15) |
|
|
|
|
|
34 Mechanisms of Cardiac Arrhythmias |
|
|
619 | (29) |
|
|
|
|
|
|
|
35 Diagnosis of Cardiac Arrhythmias |
|
|
648 | (22) |
|
|
|
|
|
|
|
Guidelines: Ambulatory Electrocardiographic and Electrophysiologic Testing |
|
|
663 | (83) |
|
|
|
|
|
|
|
36 Therapy for Cardiac Arrhythmias |
|
|
670 | (36) |
|
|
|
|
|
|
|
37 Supraventricular Arrhythmias |
|
|
706 | (24) |
|
|
|
|
|
38 Atrial Fibrillation: Clinical Features, Mechanisms, and Management |
|
|
730 | (23) |
|
|
|
|
|
Guidelines: Atrial Fibrillation |
|
|
746 | (54) |
|
|
|
|
|
39 Ventricular Arrhythmias |
|
|
753 | (19) |
|
|
|
|
|
|
|
40 Bradyarrhythmias and Atrioventricular Block |
|
|
772 | (8) |
|
|
|
|
|
41 Pacemakers and Implantable Cardioverter-Defibrillators |
|
|
780 | (27) |
|
|
|
|
|
|
|
Guidelines: Cardiac Pacemakers and Cardioverter-Defibrillators |
|
|
800 | (156) |
|
|
|
|
|
|
|
42 Cardiac Arrest and Sudden Cardiac Death |
|
|
807 | (41) |
|
|
|
|
|
43 Hypotension and Syncope |
|
|
848 | (11) |
|
|
|
|
| Part VI: Preventive Cardiology |
|
|
44 The Vascular Biology of Atherosclerosis |
|
|
859 | (17) |
|
|
|
45 Risk Markers and the Primary Prevention of Cardiovascular Disease |
|
|
876 | (34) |
|
|
|
|
|
|
|
46 Systemic Hypertension: Mechanisms and Diagnosis |
|
|
910 | (18) |
|
|
|
47 Systemic Hypertension: Management |
|
|
928 | (32) |
|
|
|
|
|
Guidelines: Treatment of Hypertension |
|
|
956 | (23) |
|
|
|
|
|
48 Lipoprotein Disorders and Cardiovascular Disease |
|
|
960 | (23) |
|
|
|
|
|
Guidelines: Lipid Management |
|
|
979 | (48) |
|
|
|
|
|
49 Nutrition and Cardiovascular and Metabolic Diseases |
|
|
983 | (15) |
|
|
|
50 Obesity and Cardiometabolic Disease |
|
|
998 | (9) |
|
|
|
|
|
|
|
51 Diabetes and the Cardiovascular System |
|
|
1007 | (25) |
|
|
|
|
|
|
|
Guidelines: Diabetes and Heart Disease |
|
|
1027 | (145) |
|
|
|
|
|
|
|
52 Air Pollution and Cardiovascular Disease |
|
|
1032 | (6) |
|
|
|
53 Exercise and Sports Cardiology |
|
|
1038 | (8) |
|
|
|
|
|
54 Exercise-Based, Comprehensive Cardiac Rehabilitation |
|
|
1046 | (6) |
|
|
|
|
|
55 Integrative Approaches to the Management of Patients with Heart Disease |
|
|
1052 | (7) |
|
|
| Part VII: Atherosclerotic Cardiovascular Disease |
|
|
56 Approach to the Patient with Chest Pain |
|
|
1059 | (10) |
|
|
|
|
|
57 Coronary Blood Flow and Myocardial Ischemia |
|
|
1069 | (26) |
|
|
|
|
|
58 ST-Elevation Myocardial Infarction: Pathophysiology and Clinical Evolution |
|
|
1095 | (28) |
|
|
|
|
|
|
|
59 ST-Elevation Myocardial Infarction: Management |
|
|
1123 | (58) |
|
|
|
|
|
Guidelines: Management of Patients with ST-Elevation Myocardial Infarction |
|
|
1172 | (30) |
|
|
|
60 Non-ST Elevation Acute Coronary Syndromes |
|
|
1181 | (28) |
|
|
|
|
|
Guidelines: Non-ST Elevation Acute Coronary Syndromes |
|
|
1202 | (56) |
|
|
|
|
|
61 Stable Ischemic Heart Disease |
|
|
1209 | (62) |
|
|
|
|
|
Guidelines: Stable lschemic Heart Disease |
|
|
1258 | (29) |
|
|
|
|
|
62 Percutaneous Coronary Intervention |
|
|
1271 | (24) |
|
|
|
|
|
Guidelines: Percutaneous Coronary Intervention |
|
|
1287 | (38) |
|
|
|
|
|
|
|
1295 | (33) |
|
|
|
|
|
Guidelines: Diseases of the Aorta |
|
|
1325 | (22) |
|
|
|
|
|
64 Peripheral Artery Diseases |
|
|
1328 | (24) |
|
|
|
|
|
Guidelines: Peripheral Artery Diseases |
|
|
1347 | (126) |
|
|
|
|
|
65 Prevention and Management of lschemic Stroke |
|
|
1352 | (13) |
|
|
|
66 Treatment of Noncoronary Obstructive Vascular Disease |
|
|
1365 | (18) |
|
|
|
|
| Part VIII: Diseases Of The Heart Valves |
|
|
67 Approach to the Patient with Valvular Heart Disease |
|
|
1383 | (6) |
|
|
|
|
|
|
|
1389 | (26) |
|
|
|
|
|
|
|
|
|
1415 | (30) |
|
James D. Thomas, Robert O. Bonow |
|
|
70 Tricuspid, Pulmonic, and Multivalvular Disease |
|
|
1445 | (10) |
|
|
|
71 Prosthetic Heart Valves |
|
|
1455 | (9) |
|
|
|
|
|
72 Transcatheter Therapies for Valvular Heart Disease |
|
|
1464 | (19) |
|
|
|
|
|
Guidelines: Management of Valvular Heart Disease |
|
|
1473 | (34) |
|
|
|
|
|
73 Cardiovascular Infections |
|
|
1483 | (27) |
|
|
|
|
|
|
|
|
|
Guidelines: Infective Endocarditis |
|
|
1507 | (287) |
|
|
|
|
|
|
|
|
|
|
|
|
|
1510 | (9) |
|
|
| Part IX: Diseases Of The Myocardium, Pericardium, And Pulmonary Vasculature Bed |
|
|
75 Congenital Heart Disease in the Adult and Pediatric Patient |
|
|
1519 | (55) |
|
|
|
|
|
|
|
|
|
76 Catheter-Based Treatment of Congenital Heart Disease in Adults |
|
|
1574 | (6) |
|
|
|
|
|
77 The Dilated, Restrictive, and Infiltrative Cardiomyopathies |
|
|
1580 | (22) |
|
|
|
|
|
78 Hypertrophic Cardiomyopathy |
|
|
1602 | (15) |
|
|
|
|
|
|
|
|
|
1617 | (14) |
|
|
|
|
|
80 Cardiomyopathies Induced by Drugs or Toxins |
|
|
1631 | (10) |
|
|
|
|
|
|
|
1641 | (10) |
|
|
|
82 Cardiovascular Abnormalities in HIV-Infected Individuals |
|
|
1651 | (11) |
|
|
|
|
|
|
|
1662 | (19) |
|
|
|
|
|
|
|
1681 | (18) |
|
|
|
85 Pulmonary Hypertension |
|
|
1699 | (21) |
|
|
|
|
|
86 Chronic Lung Diseases and Cardiovascular Disease |
|
|
1720 | (6) |
|
|
|
|
|
87 Sleep-Disordered Breathing and Cardiac Disease |
|
|
1726 | (9) |
|
|
| Part X: Cardiovascular Disease In Special Populations |
|
|
88 Cardiovascular Disease in the Elderly |
|
|
1735 | (32) |
|
|
|
|
|
|
|
89 Cardiovascular Disease in Women |
|
|
1767 | (13) |
|
|
|
|
|
90 Pregnancy and Heart Disease |
|
|
1780 | (19) |
|
|
|
|
|
Guidelines: Pregnancy and Heart Disease |
|
|
1794 | (5) |
|
|
|
|
|
91 Cardiovascular Disease in Heterogeneous Populations |
|
|
1799 | (8) |
|
|
|
|
| Part XI: Cardiovascular Disease And Disorders Of Other Organs |
|
|
92 Endocrine Disorders and Cardiovascular Disease |
|
|
1807 | (15) |
|
|
|
|
|
93 Hemostasis, Thrombosis, Fibrinolysis, and Cardiovascular Disease |
|
|
1822 | (25) |
|
|
|
94 Rheumatic Diseases and the Cardiovascular System |
|
|
1847 | (19) |
|
|
|
95 Tumors Affecting the Cardiovascular System |
|
|
1866 | (13) |
|
|
|
|
|
|
|
96 Psychiatric and Behavioral Aspects of Cardiovascular Disease |
|
|
1879 | (11) |
|
|
|
|
|
97 Neurologic Disorders and Cardiovascular Disease |
|
|
1890 | (20) |
|
|
|
|
|
|
|
98 Interface Between Renal Disease and Cardiovascular Illness |
|
|
1910 | (20) |
|
|
|
99 Cardiovascular Manifestations of Autonomic Disorders |
|
|
1930 | |
|
|
|
|
